Volume 13, Issue 2 (4-2016)                   Mod Care J 2016, 13(2): 0-0 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ghorbani S, Foadoddini M, Hasanpour Fard M, Mahdiabadi M A, Vejdan S A K. The Effects of Quercetin Topical Cream on Phlebitis Caused by Peripheral Intravenous Catheters: A Randomized Controlled Trial. Mod Care J 2016; 13 (2)
URL: http://mcj.bums.ac.ir/article-1-46-en.html
The Effects of Quercetin Topical Cream on Phlebitis Caused by Peripheral Intravenous Catheters: A Randomized Controlled Trial
Sakineh Ghorbani1 , Mohsen Foadoddini *2 , Mohammad Hasanpour Fard3 , Mohammad Ali Mahdiabadi4 , Sayed Amir Kazem Vejdan5
1- Committee Research Center, Faculty of Nursing, Birjand University of Medical Sciences, Birjand, IR Iran
2- Mohsen Foadoddini, Associated Professor of Physiology, Atherosclerosis and Coronary Artery Research Center, Department of Physiology, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, IR Iran. Tel: +98-5632440488, Fax: +98-5632440488, E-mail: foadmohsen@yahoo.com
3- Berberis and Jujube Research Center, Birjand University of Medical Sciences, Birjand, IR Iran
4- Department of Internal, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, IR Iran
5- Department of Surgery, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, IR Iran
Abstract:   (16 Views)
Background: Phlebitis is among the most common complications of intravenous therapy. It significantly correlates with the length of hospital stay and mortality rate. Objectives: This study sought to examine the effects of quercetin topical cream on phlebitis caused by peripheral intravenous catheters. Methods: This single-blind randomized controlled trial was done in 2015 on 66 patients hospitalized at the internal medicine ward of Valiasr (PBUH) hospital, Birjand, Iran. The patients were conveniently recruited and randomly allocated to a control and an experimental group. The data collection tool was a five-point phlebitis assessment scale. As soon as the symptoms of phlebitis were observed, the related catheter was removed and the catheter insertion site was treated every twelve hours for 72 hours with either 2% quercetin cream (the experimental group) or a eucerin-based cream (the control group). Friedman, Wilcoxon and Mann-Whitney U tests were run using the SPSS software for data analysis (v. 14.0). Results: There was no significant difference between the groups regarding patients’ age (P = 0.068) and gender (P = 0.69). No significant changes were observed in the severity of phlebitis in the control group during the 72-hour course of the study. However, in the quercetin group, the severity of phlebitis decreased significantly after twelve hours from the beginning of the intervention and the trend of its variations was downward (P < 0.001). Consequently, after 72 hours (or six episodes of quercetin cream use), 90% of all phlebitis cases achieved complete recovery without any side effect. Conclusions: 2% Quercetin cream could be effective in treating phlebitis caused by intravenous catheters and can be used as a useful and safe treatment modality for phlebitis management. The positive effects of quercetin on phlebitis appear very soon after its use.
Keywords: Phlebitis, Quercetin, Intravenous Catheter, and Intravenous Fluid Therapy
Full-Text [PDF 114 kb]   (17 Downloads)    
Article Types: Research Article | Subject: General
Received: 2026/01/10 | Accepted: 2016/04/15 | Published: 2016/04/15
Add your comments about this article : Your username or Email:
CAPTCHA
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Modern Care Journal

Designed & Developed by : Yektaweb